175 related articles for article (PubMed ID: 31027900)
21. The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer.
Bakkum-Gamez JN; Mariani A; Dowdy SC; Weaver AL; McGree ME; Cliby WA; Gostout BS; Stanhope CR; Wilson TO; Podratz KC
Gynecol Oncol; 2011 Oct; 123(1):58-64. PubMed ID: 21741696
[TBL] [Abstract][Full Text] [Related]
22. A cost-effectiveness analysis of three approaches for lymph node assessment in patients with low- and intermediate-risk endometrial cancer.
Burg LC; Vermeulen RJ; Bekkers RLM; Wijn SRW; Rovers MM; Govers TM; Zusterzeel PLM
Gynecol Oncol; 2021 Apr; 161(1):251-260. PubMed ID: 33581847
[TBL] [Abstract][Full Text] [Related]
23. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
24. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
25. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
[TBL] [Abstract][Full Text] [Related]
26. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
[TBL] [Abstract][Full Text] [Related]
27. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
[TBL] [Abstract][Full Text] [Related]
28. The Role of Lymphadenectomy Versus Sentinel Lymph Node Biopsy in Early-stage Endometrial Cancer: A Review of the Literature.
Tschernichovsky R; Diver EJ; Schorge JO; Goodman A
Am J Clin Oncol; 2016 Oct; 39(5):516-21. PubMed ID: 27281265
[TBL] [Abstract][Full Text] [Related]
29. Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study.
Coronado PJ; Rychlik A; Martínez-Maestre MA; Baquedano L; Fasero M; García-Arreza A; Morales S; Lubian DM; Zapardiel I
J Gynecol Oncol; 2018 Jan; 29(1):e1. PubMed ID: 29185259
[TBL] [Abstract][Full Text] [Related]
30. Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer.
Kim NR; So KA; Kim TJ; Lim K; Lee KH; Kim MK
J Gynecol Oncol; 2023 May; 34(3):e23. PubMed ID: 36562131
[TBL] [Abstract][Full Text] [Related]
31. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
[TBL] [Abstract][Full Text] [Related]
32. Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer.
Kilts TP; Glaser GE; Langstraat CL; Kumar A; Weaver AL; Mc Gree ME; Gostout BS; Podratz KC; Dowdy SC; Cliby WA; Mariani A; Bakkum-Gamez JN
Gynecol Oncol; 2019 Oct; 155(1):21-26. PubMed ID: 31409487
[TBL] [Abstract][Full Text] [Related]
33. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
Barlin JN; Khoury-Collado F; Kim CH; Leitao MM; Chi DS; Sonoda Y; Alektiar K; DeLair DF; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2012 Jun; 125(3):531-5. PubMed ID: 22366409
[TBL] [Abstract][Full Text] [Related]
34. [Lymph node dissection in endometrial cancer type I].
Ismail E; Kornovski Y; Slavchev S
Akush Ginekol (Sofiia); 2012; 51(7):8-11. PubMed ID: 23610910
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
Ivanov S; Tomov S
Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
[TBL] [Abstract][Full Text] [Related]
36. Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis.
Papathemelis T; Hassas D; Gerken M; Klinkhammer-Schalke M; Scharl A; Lux MP; Beckmann MW; Scharl S
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2019-2027. PubMed ID: 30039227
[TBL] [Abstract][Full Text] [Related]
37. Endometrial cancer-how many patients could benefit from sentinel lymph node dissection?
Brugger S; Hamann M; Mosner M; Beer M; Braun M; Pölcher M
World J Surg Oncol; 2018 May; 16(1):95. PubMed ID: 29773071
[TBL] [Abstract][Full Text] [Related]
38. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer.
Dowdy SC; Borah BJ; Bakkum-Gamez JN; Weaver AL; McGree ME; Haas LR; Keeney GL; Mariani A; Podratz KC
Gynecol Oncol; 2012 Oct; 127(1):5-10. PubMed ID: 22771890
[TBL] [Abstract][Full Text] [Related]
39. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
Venigalla S; Chowdhry AK; Shalowitz DI
Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
[TBL] [Abstract][Full Text] [Related]
40. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
